Sum Microdose Expands into California
KelSie Biotech today announced its expansion into the California market with a manufacturing and
licensing deal with Verde Natural, a highly successful Colorado and California based manufacturer of top-
quality cannabis products. This expansion follows on the heels of explosive growth for Kelsie’s SUM
Microdose brand with over 30% quarter-over-quarter growth and distribution expansion into more than
130 Colorado dispensaries.
Verde, led by founder Jeff Damavandi and COO Andrew Salini, is a highly respected leader in
the cannabis industry – as a premium cultivator and retailer. The deal makes Verde the
producer and distributor of SUM Microdose for both Colorado and Verde’s newest market,
California, and allows KelSie to continue to focus on science-based product and patent
“Verde is honored to be chosen by KelSie Biotech,” said Damavandi. “We are laser-focused on
producing the highest quality products and SUM fits that ethos – while helping us expand to
completely new consumers.”
KelSie continues to actively pursue expansion with operating partners in other geographies.
Growing Product Line: Announcing Launch of SUM Sleep
In July 2018, SUM launched with four patented and fast-acting, water-soluble sublingual tablet
SKUs: Calm, Relief, Focus, and Energy. Midyear, it expanded the line to include a topical (rollon) SUM Relief product for direct application to sore muscles and joints. And, this week, the
lineup expands with the launch of SUM Sleep in its sublingual tablet format.
SUM Sleep employs the naturally sedative effect of a cannabinoid called Cannabinol or CBN.
Combined with a microdose of THC, CBN triggers the body’s own sleep cycle without the use of
hormones such as melatonin or the side effects found in pharmaceutical sleep aids. The result
is a deep, natural, restful sleep. And, as a sublingual absorbed through the mucosa, it bypasses
the stomach to work in mere minutes. It also provides a more desirable consumer experience
than oils that tend to pool up and get swallowed.
“What we hear most from our dispensary partners,” notes KelSie CMO Steven Addis, “is that
SUM replaces edibles and tinctures. In fact, some dispensaries have entirely replaced tinctures
with SUM and we’re helping them create Microdose sections inside their stores to improve the
shopping experience for the fast-growing wellness audience.”
Series A Financing
KelSie Biotech recently announced closing the first tranche of $5 million Series A funding. The
investment round, led by Salveo Capital, a leading cannabis focused investment firm, with
participation from LA-based Arcadian Capital and other investors, will support the company’s
scientific research and market expansion. The second closing, open to accredited investors, is
expected to be completed in September 2019.
“We constantly look for new and innovative technology that drives consumption patterns and
introduces healthier and more discreet form factors across the pharma industry,” said Jeffrey
Howard, a Managing Partner at Salveo Capital. “We are impressed with KelSie’s strong
patented and proprietary technology, including their true sublingual delivery systems with quick
The Microdose Movement
KelSie Biotech believes we are witnessing the beginning of a Microdose Movement for
cannabinoid selfcare. With funding in place, a growing team of operating partners beginning
with Verde Natural, and an expanding line of uniquely effective products, SUM Microdose will
continue to lead the Movement.
About KelSie Biotech
The people of Kelsie Biotech are passionate to make the delivery of active pharmaceutical
ingredients (APIs) more effective, safer, and less invasive. Whether licensing its patented
technology to pharmaceutical companies or to operating partners in the CBD/cannabis space,
KelSie pioneers highly bioavailable delivery methods with a wide range of applications.
KelSie’s backstory comes from science beyond cannabis. Its patented micro-powder was first
developed thanks to a $20M Bill and Melinda Gates Foundation grant to revolutionize measles
vaccine delivery. The recipient of that grant, Dr. Robert Sievers, developed a replacement for
expensive, needle-based, perishable vaccines in developing countries. After his dry-inhaled
powder technology successfully completed Phase I Clinical Trials for delivery of a stable
measles vaccine, Dr. Sievers focused his patented superior drug delivery methods to other
active pharmaceutical ingredients (APIs). A group of scientists and researchers gathered
around Dr. Sievers to create KelSie Biotech.
KelSie Biotech’s patented and proprietary technologies are based on novel particle morphology
science and include dry-inhaled powder and true sublingual delivery systems. KelSie creates
high bioavailability delivery methods for active pharmaceutical ingredients in the medical,
nutraceutical, and CBD/cannabis fields.
About Salveo Capital
Launched at the end of 2016, Salveo Capital is a venture capital firm specializing in the
legalized cannabis space, making investments across the entire cannabis supply chain. Salveo
Capital's approach is to bring an institutional quality discipline to company vetting, investment
structures and portfolio management. The Firm is committed to shaping the early-stage, yet
rapidly growing, industry by providing funding and development to companies with the will and
vision to be the pioneers of legalized marijuana. As cannabis legalization spreads, Salveo
Capital seeks to build long term sustainable companies and support innovative technologies,
products and services to help address the unique requirements of the industry. The firm is
based in Northbrook, Illinois, and with vertical industry executives and cannabis operating
advisors across the country, including key markets of California and Colorado. For more
information, please visit www.salveocapital.com.
About Verde Natural
Founded in Colorado in 2009, Verde Natural has established itself as an industry leading
cultivator and retailer known for producing connoisseur grade cannabis flowers using its
proprietary living soil, organically fed, cultivation methodology. Verde’s living soil process was
originally developed in fabled Humboldt, CA during the early days of the medical market, based
on the belief that cannabis is a medicine with panacea-like healing properties and therefore,
should only be grown as nature intended—using only organic inputs in living soil. The Verde
Family of Brands has grown into a fully vertically integrated medical and recreational cultivator,
retailer, wholesaler and extractor, offering both high quality hydrocarbon (Fuego Extracts) and
solventless (Dablogic) hash, edibles, and vaporizer products in Colorado and California; now
including SUM Microdose. Paramount to all of Verde’s brands is a commitment to quality,
sustainability, and customer education.
Direct inquiries (press, investment, state licensing) to: